In this model, functional Treg cells prevent the development of inflammatory bowel disease (IBD) characterized by the differentiation of naive CD4+ T cells into Th1 and Th17 cells and lymphocytic inflammation of the large intestine. This evidence concerns the gene CD4 and inflammatory bowel disease.